Paternal phenylketonuria - 07/10/17
Doi : 10.1016/S0022-3476(05)80038-1
Harvey L. Levy, MD a, b, c, d, e, ⁎, Deborah Lobbregt, BS a, b, c, d, e, Richard Koch, MD a, b, c, d, e, Felix de la Cruz, MD, MPH a, b, c, d, e
a Biochemical Genetics Unit, Division of Genetics, Children's Hospital, Boston, USA
b Department of Neurology, Harvard Medical School, Boston, USA
c Newborn Screening Program, State Laboratory Institute, Massachusetts Department of Public Health, Boston, USA
d Division of Medical Genetics, Children's Hospital of Los Angeles, Los Angeles, California, USA
e National Institute of Child Health and Human Development, Bethesda, Maryland, USA
1Reprint requests: Harvey L. Levy, MD, Children's Hospital, Gardner 648, 300 Longwood Ave., Boston, MA 02115.
| * | Supported by contract No. NO1-HD-4-2809 for the Maternal PKU Collaborative Study from the National Institutes of Health. |
© 1991
Publié par Elsevier Masson SAS.
Vol 118 - N° 5
P. 741-743 - mai 1991 Retour au numéro
Article précédent
- Children of fathers with phenylketonuria: An international survey
- Robert O. Fisch, Reuben Matalon, Sandy Weisberg, Kimberlee Michals
- Progressive neuropathy and recurrent myoglobinuria in a child with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency
- Carlo Dionisi Vici, Alberto B. Burlina, Enrico Bertini, Claude Bachmann, Mercedes R.M. Mazziotta, F. Zacchello, Gaetano Sabetta, Daniel E. Hale
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?